146 related articles for article (PubMed ID: 21226857)
21. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
22. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic index in malignant melanoma. A better method to determine metastasis risk].
Schmoeckel C; Nejad KK; Braun-Falco O
Pathologe; 1980 Feb; 1(2):71-8. PubMed ID: 7208436
[No Abstract] [Full Text] [Related]
24. Malignant melanoma: prognostic factors and therapeutic results.
DeVita VT; Fisher RI
W V Med J; 1977 Aug; 73(8):167-72. PubMed ID: 268079
[No Abstract] [Full Text] [Related]
25. Carcinoma renegades. Why do tumors spread?
Tangley L
US News World Rep; 2000 Aug; 129(6):47. PubMed ID: 11010050
[No Abstract] [Full Text] [Related]
26. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
Mastrangelo MJ; Maguire HC; Eisenlohr LC; Laughlin CE; Monken CE; McCue PA; Kovatich AJ; Lattime EC
Cancer Gene Ther; 1999; 6(5):409-22. PubMed ID: 10505851
[TBL] [Abstract][Full Text] [Related]
27. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy].
Ehring F
Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115
[TBL] [Abstract][Full Text] [Related]
28. Disease progression in patients with thin cutaneous melanomas.
Nicolaou N; Morris A; Motley R
Br J Dermatol; 2004 Jun; 150(6):1223; author reply 1224. PubMed ID: 15214924
[No Abstract] [Full Text] [Related]
29. Cutaneous melanoma: a model to study cancer metastasis.
Leong SP; Gershenwald JE; Soong SJ; Schadendorf D; Tarhini AA; Agarwala S; Hauschild A; Soon CW; Daud A; Kashani-Sabet M
J Surg Oncol; 2011 May; 103(6):538-49. PubMed ID: 21480247
[TBL] [Abstract][Full Text] [Related]
30. The newest treatments for uveal melanoma.
Luke JJ
Clin Adv Hematol Oncol; 2019 Sep; 17(9):490-493. PubMed ID: 31549969
[No Abstract] [Full Text] [Related]
31. [The adjuvant therapy of malignant melanoma].
Hauschild A; Sterry W
Dtsch Med Wochenschr; 1992 Feb; 117(8):303-6. PubMed ID: 1537268
[No Abstract] [Full Text] [Related]
32. The initiation and progression of melanoma: estrogens or estrogen receptors?
de Giorgi V; Gori A; Grazzini M; Rossari S; Sestini S; Mavilia C; Massi D; Brandi ML; Lotti T
Melanoma Res; 2010 Feb; 20(1):64-5. PubMed ID: 20051783
[No Abstract] [Full Text] [Related]
33. Melanoma gene expression and clinical course.
Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B
Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132
[TBL] [Abstract][Full Text] [Related]
34. Melanoma metastasis: new concepts and evolving paradigms.
Damsky WE; Theodosakis N; Bosenberg M
Oncogene; 2014 May; 33(19):2413-22. PubMed ID: 23728340
[TBL] [Abstract][Full Text] [Related]
35. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
Ireland A; Millward M; Pearce R; Lee M; Ziman M
Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
[TBL] [Abstract][Full Text] [Related]
36. [Monitoring of patients with stage I melanoma after excision of the primary tumor].
Eggermont AM
Ann Dermatol Venereol; 1995; 122(5):292-7. PubMed ID: 8572469
[No Abstract] [Full Text] [Related]
37. [Malignant melanoma of the skin].
Stein G
Z Haut Geschlechtskr; 1971 Jul; 46(13):409-14. PubMed ID: 5110514
[No Abstract] [Full Text] [Related]
38. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease.
Miranda EP; Gertner M; Wall J; Grace E; Kashani-Sabet M; Allen R; Leong SP
Arch Surg; 2004 Aug; 139(8):831-6; discussion 836-7. PubMed ID: 15302691
[TBL] [Abstract][Full Text] [Related]
39. Melanoma.
Clarke AM
N Z Med J; 1982 Apr; 95(705):221-2. PubMed ID: 6953359
[No Abstract] [Full Text] [Related]
40. [Therapeutic and prognostic programming in cases of malignant melanoma].
Veronesi U
Schweiz Med Wochenschr; 1970 Jun; 100(23):976-81. PubMed ID: 5524713
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
